BMY news

• Bristol-Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?

  The Motley Fool · Oct 16, 2026
• Bristol Myers Squibb's 4.2% Dividend Yield Comes With a Trade-Off Investors Should Know

  24/7 Wall Street · Oct 16, 2026
• A $600,000 Dividend Portfolio Has a $52,900 Tax Problem. Here’s the Roth Solution

  247 Wallst · Oct 15, 2026
• These 4 Dividend Stocks Passed the 2020 Stress Test. Are They Buys in Now October?

  24/7 Wall Street · Oct 14, 2026
• Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It

  Zacks Investment Research · Oct 14, 2026
• Blockbuster Drugs Come and Go. These 5 Pharma Dividend Stocks Keep Paying

  24/7 Wall Street · Oct 14, 2026
• Bristol Myers Squibb vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

  The Motley Fool · Oct 13, 2026
• BMY Reports Mixed Phase III Trial Results, Stock Down

  Zacks Investment Research · Oct 13, 2026
• FTC says Martin Shkreli 'flagrantly and repeatedly' violated his lifetime pharma ban

  Business Insider · Oct 13, 2026
• Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today

  Zacks Investment Research · Oct 12, 2026
• Bristol Myers falls 3% despite positive cancer drug trial results

  Proactive Investors · Oct 12, 2026
• Why Is Contineum Therapeutics Stock Falling Monday?

  Benzinga · Oct 12, 2026
• BMY Surges 35.7% in a Year: Should You Buy, Sell or Hold the Stock?

  Zacks Investment Research · Oct 12, 2026
• Bristol Myers Squibb (BMY) Gains on Positive Phase 3 Results for RYZ101 and Admilparant

  GuruFocus · Oct 12, 2026
• Bristol Myers Squibb Announces Positive Topline Results from the Interim Analysis of Phase 3 ACTION-1 for RYZ101, RayzeBio's Radiopharmaceutical Therapy, in Patients with GEP-NETs

  Business Wire · Oct 12, 2026
• Bristol Myers Squibb Announces Phase 3 ALOFT-IPF Trial Evaluating Admilparant in Adults with Idiopathic Pulmonary Fibrosis Met Primary Endpoint

  Business Wire · Oct 12, 2026
• Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?

  Fool - Investing News · Oct 10, 2026
• 20,370 Bristol Myers Squibb Company $BMY Shares Bought by Apella Capital LLC

  Defense World · Oct 10, 2026
• 2 Brain-Computer Interface Stocks to Watch While Neuralink Stays Private

  Investor Place · Oct 9, 2026
• Bristol Myers Squibb vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

  The Motley Fool · Oct 8, 2026
• Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?

  Zacks Investment Research · Oct 8, 2026
• Bristol Myers Squibb's Zenbexus Delivers Major Blood Cancer Win, Cuts Progression Risk 51%

  Benzinga · Oct 8, 2026
• Bristol Myers Squibb Announces ZENBEXUSTM (iberdomide) in Combination with Daratumumab and Dexamethasone (ZDd) Demonstrates Superior Progression-Free Survival vs.

  Business Wire · Oct 8, 2026
• Bristol-Myers Squibb: Balanced Segment Growth, The Pullback Is An Opportunity

  Seeking Alpha · Oct 7, 2026
• 2 High-Yield Stocks to Buy in October (Hint: Bristol Myers Squibb Is One)

  The Motley Fool · Oct 7, 2026
• Can Reblozyl Power Bristol Myers' Top-Line Growth Going Forward?

  Zacks Investment Research · Oct 7, 2026
• Here's Why Bristol Myers Squibb (BMY) is a Strong Value Stock

  Zacks Investment Research · Oct 7, 2026
• 5 Dividend Stocks With Fortress-Like Coverage and Room for Things to Go Wrong

  24/7 Wall Street · Oct 7, 2026
• BMY or ARGX: Which Is the Better Value Stock Right Now?

  Zacks Investment Research · Oct 5, 2026
• Are Investors Undervaluing Bristol Myers Squibb (BMY) Right Now?

  Zacks Investment Research · Oct 5, 2026

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.